Trial Information
Summary: Research study of an investigational medication for Major Depressive Disorder.
An eight-week, double-blind study to evaluate the efficacy, safety, and tolerability of two fixed doses of an investigational medication in combination with paroxetine compared to placebo (an inactive substance) or paroxetine in patients with Major Depressive Disorder.
Length of Study: 10 weeks
Number of Office Visits: 8 visits
Qualified participants will receive study medication and study related services at no cost. In addition, participants will be reimbursed for time and travel.
Study inclusion/exclusion criteria:
This study is only available to persons who:
- Can fluently read and speak English
- Are 18 to 65 years old
- Are without serious health problems and are sexually active
- Do not have certain conditions such as Bipolar or Obsessive-Compulsive Disorder
- Are not addicted to drugs or alcohol
Contact Us At:
California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd., Suite 104
Sherman Oaks, CA 91403
(818) 990-2671
bailey@cnrmg.com or susie@crnmg.com
|
Contact:
California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd., Suite #104
Sherman Oaks, CA 91403
Telephone: (818) 990-2671
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 24, 2008 at 4:48:24 PM